query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_3603_ESMFold_hypothetical_protein	2iok-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	2iok-assembly1.cif.gz_B Human estrogen receptor alpha ligand-binding domain in complex with compound 1D	0.156	64	52	82	144	153	216	3.567E+00	38
LOKIASV2_3603_ESMFold_hypothetical_protein	8jta-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	8jta-assembly1.cif.gz_A Human VMAT2 complex with tetrabenazine	0.146	183	149	1	175	203	385	1.434E+00	34
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujy-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7ujy-assembly1.cif.gz_B Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	0.121	150	129	4	153	73	220	1.508E+00	33
LOKIASV2_3603_ESMFold_hypothetical_protein	7d3u-assembly1.cif.gz_G	LOKIASV2_3603_ESMFold_hypothetical_protein	7d3u-assembly1.cif.gz_G Structure of Mrp complex from Dietzia sp. DQ12-45-1b	0.142	89	75	56	144	4	91	8.435E+00	32
LOKIASV2_3603_ESMFold_hypothetical_protein	2i0j-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	2i0j-assembly2.cif.gz_D Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia	0.109	142	124	8	147	72	213	2.769E+00	32
LOKIASV2_3603_ESMFold_hypothetical_protein	3os8-assembly1.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	3os8-assembly1.cif.gz_C Estrogen Receptor	0.134	153	130	7	159	72	222	1.587E+00	32
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs1-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs1-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-21	0.146	75	58	85	159	141	209	5.918E+00	31
LOKIASV2_3603_ESMFold_hypothetical_protein	6zoq-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	6zoq-assembly1.cif.gz_B Oestrogen receptor ligand binding domain in complex with compound 16	0.133	153	128	1	149	61	213	1.756E+00	30
LOKIASV2_3603_ESMFold_hypothetical_protein	5tnb-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5tnb-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	0.109	140	119	8	147	80	213	3.391E+00	30
LOKIASV2_3603_ESMFold_hypothetical_protein	5ak2-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5ak2-assembly1.cif.gz_A Oxyphenylpropenoic acids as Oral Selective Estrogen Receptor Down- Regulators.	0.109	168	139	7	174	72	228	2.379E+00	30
LOKIASV2_3603_ESMFold_hypothetical_protein	1a52-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	1a52-assembly1.cif.gz_B ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL	0.132	171	147	1	171	66	235	1.847E+00	30
LOKIASV2_3603_ESMFold_hypothetical_protein	8dud-assembly1.cif.gz_A-2	LOKIASV2_3603_ESMFold_hypothetical_protein	8dud-assembly1.cif.gz_A-2 Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(1-propylpyrrolidin-3-yl)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.128	141	120	4	144	72	210	4.594E+00	29
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs9-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs9-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-25	0.151	78	61	82	159	142	214	6.548E+00	29
LOKIASV2_3603_ESMFold_hypothetical_protein	6wok-assembly2.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	6wok-assembly2.cif.gz_B Crystal structure of estrogen receptor alpha in complex with receptor degrader 6	0.129	142	123	6	147	75	216	2.379E+00	29
LOKIASV2_3603_ESMFold_hypothetical_protein	5tn1-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5tn1-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol derivative, (8S,9S,13S,14S,E)-17-((4-isopropylphenyl)imino)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol	0.121	184	156	1	184	67	244	1.296E+00	29
LOKIASV2_3603_ESMFold_hypothetical_protein	7zc2-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7zc2-assembly1.cif.gz_A Dipeptide and tripeptide Permease C (DtpC)	0.110	183	142	4	163	265	447	2.633E+00	29
LOKIASV2_3603_ESMFold_hypothetical_protein	5a43-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5a43-assembly1.cif.gz_B Crystal structure of a dual topology fluoride ion channel.	0.157	122	91	33	141	3	124	2.503E+00	28
LOKIASV2_3603_ESMFold_hypothetical_protein	7uj7-assembly1.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	7uj7-assembly1.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with RU39411	0.143	141	120	4	144	69	209	3.223E+00	28
LOKIASV2_3603_ESMFold_hypothetical_protein	8duk-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	8duk-assembly2.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(methylamino)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.131	169	135	7	175	69	224	3.223E+00	28
LOKIASV2_3603_ESMFold_hypothetical_protein	3osa-assembly1.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	3osa-assembly1.cif.gz_C Estrogen Receptor	0.145	179	136	4	182	70	229	1.847E+00	28
LOKIASV2_3603_ESMFold_hypothetical_protein	2r6y-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	2r6y-assembly1.cif.gz_A Estrogen receptor alpha ligand-binding domain in complex with a SERM	0.142	150	126	6	153	73	222	2.633E+00	28
LOKIASV2_3603_ESMFold_hypothetical_protein	2q70-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	2q70-assembly1.cif.gz_A Estrogen receptor alpha ligand-binding domain complxed to a benzopyran ligand	0.128	151	130	4	153	75	225	2.503E+00	28
LOKIASV2_3603_ESMFold_hypothetical_protein	6vjd-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	6vjd-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	0.144	158	132	6	163	76	230	3.947E+00	28
LOKIASV2_3603_ESMFold_hypothetical_protein	4iw8-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	4iw8-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 9a	0.126	184	150	1	184	66	238	2.633E+00	28
LOKIASV2_3603_ESMFold_hypothetical_protein	3osa-assembly2.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	3osa-assembly2.cif.gz_B Estrogen Receptor	0.145	140	118	6	144	80	219	4.152E+00	28
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs7-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs7-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	0.141	144	123	6	149	81	224	2.913E+00	28
LOKIASV2_3603_ESMFold_hypothetical_protein	7tx6-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7tx6-assembly1.cif.gz_A Cryo-EM structure of the human reduced folate carrier in complex with methotrexate	0.121	170	145	6	171	7	176	3.752E+00	28
LOKIASV2_3603_ESMFold_hypothetical_protein	6bx5-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6bx5-assembly1.cif.gz_A The crystal structure of fluoride channel Fluc Ec2 with Monobody S12	0.157	122	91	33	141	3	124	5.626E+00	27
LOKIASV2_3603_ESMFold_hypothetical_protein	7kka-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7kka-assembly1.cif.gz_B Fluoride channel Fluc-Ec2 mutant S81A with bromide	0.137	122	93	33	141	3	124	2.913E+00	27
LOKIASV2_3603_ESMFold_hypothetical_protein	7uzh-assembly1.cif.gz_m	LOKIASV2_3603_ESMFold_hypothetical_protein	7uzh-assembly1.cif.gz_m Rat Kidney V-ATPase with SidK, State 2	0.128	142	121	4	143	8	149	5.084E+00	27
LOKIASV2_3603_ESMFold_hypothetical_protein	6dfn-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	6dfn-assembly2.cif.gz_D Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa	0.164	144	116	6	149	71	210	4.152E+00	27
LOKIASV2_3603_ESMFold_hypothetical_protein	3osa-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	3osa-assembly2.cif.gz_D Estrogen Receptor	0.110	156	127	4	159	70	213	3.064E+00	27
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujo-assembly2.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	7ujo-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411	0.162	170	132	4	173	75	233	3.752E+00	27
LOKIASV2_3603_ESMFold_hypothetical_protein	5kra-assembly2.cif.gz_F	LOKIASV2_3603_ESMFold_hypothetical_protein	5kra-assembly2.cif.gz_F Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE	0.135	184	146	1	184	66	235	2.913E+00	27
LOKIASV2_3603_ESMFold_hypothetical_protein	7n9o-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	7n9o-assembly2.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain in Complex with Aliphatic SERD S-C10(15)	0.114	176	151	6	181	65	235	3.064E+00	27
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujm-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7ujm-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative That Increases Receptor Resonance Time in the Nucleus of Breast Cancer Cells	0.140	172	140	4	175	73	236	4.152E+00	27
LOKIASV2_3603_ESMFold_hypothetical_protein	3osa-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	3osa-assembly1.cif.gz_A Estrogen Receptor	0.144	168	136	6	173	80	239	2.262E+00	27
LOKIASV2_3603_ESMFold_hypothetical_protein	6vjd-assembly2.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	6vjd-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	0.138	172	141	3	174	74	238	3.947E+00	27
LOKIASV2_3603_ESMFold_hypothetical_protein	7yub-assembly1.cif.gz_R	LOKIASV2_3603_ESMFold_hypothetical_protein	7yub-assembly1.cif.gz_R S1P-bound human SPNS2	0.141	166	136	6	171	21	179	5.918E+00	27
LOKIASV2_3603_ESMFold_hypothetical_protein	7zha-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7zha-assembly1.cif.gz_A Structure of human OCT3 in complex with inhibitor decynium-22	0.141	153	124	6	158	307	451	3.391E+00	27
LOKIASV2_3603_ESMFold_hypothetical_protein	2q70-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	2q70-assembly1.cif.gz_B Estrogen receptor alpha ligand-binding domain complxed to a benzopyran ligand	0.108	142	124	7	146	69	210	6.548E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	7rrx-assembly2.cif.gz_D-3	LOKIASV2_3603_ESMFold_hypothetical_protein	7rrx-assembly2.cif.gz_D-3 Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-19	0.135	138	112	6	143	71	200	3.947E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	8dub-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	8dub-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with ((1'-(4-((1-ethylpyrrolidin-3-yl)methyl)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.117	147	126	1	144	56	202	3.567E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	5tn9-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	5tn9-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	0.123	137	116	8	144	73	205	3.567E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	2bj4-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	2bj4-assembly1.cif.gz_B ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST	0.121	155	129	1	148	67	221	4.152E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	7rry-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7rry-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-20	0.140	139	119	6	144	72	210	4.368E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	8duk-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	8duk-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(methylamino)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.126	170	146	6	175	58	225	2.262E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	5dxq-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5dxq-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(1s,5s)-bicyclo[3.3.1]non-9-ylidenemethanediyl]diphenol	0.116	184	147	1	184	60	226	2.379E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs1-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs1-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-21	0.139	156	125	4	159	70	215	3.391E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	7rrz-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7rrz-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	0.103	152	127	6	148	65	216	3.391E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	7r62-assembly1.cif.gz_A-2	LOKIASV2_3603_ESMFold_hypothetical_protein	7r62-assembly1.cif.gz_A-2 Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Desmethyl ICI164,384 Derivative	0.150	171	136	4	174	73	233	4.368E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	5die-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5die-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoro-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-7a-methyl-5-(2,3,5-trifluoro-4-hydroxyphenyl)octahydro-1H-inden-1-ol	0.126	184	149	1	184	64	234	3.752E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	1sj0-assembly1.cif.gz_A-2	LOKIASV2_3603_ESMFold_hypothetical_protein	1sj0-assembly1.cif.gz_A-2 Human Estrogen Receptor Alpha Ligand-binding Domain in Complex with the Antagonist Ligand 4-D	0.140	169	139	8	176	79	241	4.368E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	8dwi-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	8dwi-assembly1.cif.gz_A Molecular Mechanism of Sialic Acid Transport Mediated by Sialin	0.140	190	160	6	192	28	217	6.225E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	4ybq-assembly2.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	4ybq-assembly2.cif.gz_B Rat GLUT5 with Fv in the outward-open form	0.119	167	129	2	168	47	193	3.064E+00	26
LOKIASV2_3603_ESMFold_hypothetical_protein	6b24-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6b24-assembly1.cif.gz_A Crystal structure of fluoride channel Fluc Ec2 F80Y Mutant	0.152	122	92	33	141	2	123	4.368E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	6wm4-assembly1.cif.gz_2	LOKIASV2_3603_ESMFold_hypothetical_protein	6wm4-assembly1.cif.gz_2 Human V-ATPase in state 3 with SidK and ADP	0.128	144	120	1	139	3	146	3.223E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	7rry-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	7rry-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-20	0.155	139	109	6	144	70	199	3.947E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs0-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs0-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-18	0.160	137	114	6	142	70	206	3.947E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	5tsb-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5tsb-assembly1.cif.gz_A Crystal structure of the Zrt-/Irt-like protein from Bordetella bronchiseptica with bound Cd2+	0.151	149	117	1	139	28	176	5.084E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	7wnv-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	7wnv-assembly2.cif.gz_D Crystal structure of mutant estrogen receptor alpha Y537S in complex with CO9	0.153	143	115	4	146	78	214	5.348E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	2qzo-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	2qzo-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with WAY-169916	0.127	184	140	1	184	66	226	2.503E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	5tnb-assembly2.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	5tnb-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	0.109	142	122	7	148	79	216	6.888E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	5aav-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5aav-assembly1.cif.gz_A Optimization of a novel binding motif to to (E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H- pyrido(3,4-b)indol-1-yl)phenyl)acrylic acid (AZD9496), a potent and orally bioavailable selective estrogen receptor downregulator and antagonist	0.160	86	66	88	173	154	232	9.333E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	1r5k-assembly2.cif.gz_C-2	LOKIASV2_3603_ESMFold_hypothetical_protein	1r5k-assembly2.cif.gz_C-2 Human Estrogen Receptor alpha Ligand-Binding Domain In Complex With GW5638	0.123	166	135	6	171	76	230	4.152E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	8duk-assembly2.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	8duk-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(methylamino)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.152	172	135	4	175	77	236	2.503E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	6zor-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6zor-assembly1.cif.gz_A Oestrogen receptor ligand binding domain in complex with compound 28	0.141	169	133	6	174	83	238	3.064E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	5dkg-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5dkg-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a t-butyl-substituted, methyl, triaryl-ethylene derivative 4,4'-[2-(4-tert-butylphenyl)prop-1-ene-1,1-diyl]diphenol	0.131	184	149	1	184	66	238	4.368E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	2qab-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	2qab-assembly1.cif.gz_B Crystal Structure of Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with an Ethyl Indazole Compound	0.130	184	154	1	184	66	243	3.567E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	7xq1-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7xq1-assembly1.cif.gz_A Structure of hSLC19A1+2'3'-CDAS	0.126	202	163	6	192	11	212	4.833E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	4u4w-assembly2.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	4u4w-assembly2.cif.gz_B Structure of a nitrate/nitrite antiporter NarK in nitrate-bound occluded state	0.150	112	91	4	111	35	146	6.888E+00	25
LOKIASV2_3603_ESMFold_hypothetical_protein	5fdr-assembly2.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5fdr-assembly2.cif.gz_B Mcl-1 complexed with small molecule inhibitor	0.104	152	127	2	153	1	143	8.435E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	5tn9-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5tn9-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	0.123	144	113	6	149	71	200	6.548E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	2bj4-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	2bj4-assembly1.cif.gz_A ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST	0.140	157	125	1	146	61	217	4.152E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	8dus-assembly2.cif.gz_F	LOKIASV2_3603_ESMFold_hypothetical_protein	8dus-assembly2.cif.gz_F Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-(2-(ethylamino)ethoxy)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.177	169	123	6	174	70	219	4.594E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	2i0j-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	2i0j-assembly1.cif.gz_A Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia	0.106	156	130	1	146	65	220	7.622E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	3uuc-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	3uuc-assembly1.cif.gz_A Crystal structure of hERa-LBD (wt) in complex with bisphenol-C	0.102	144	123	8	151	78	215	8.018E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	6pfm-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6pfm-assembly1.cif.gz_A Crystal structure of GDC-0927 bound to estrogen receptor alpha	0.122	161	129	1	148	64	224	4.152E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	6pet-assembly2.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	6pet-assembly2.cif.gz_B Crystal structure of 8-hydroxychromene compound 30 bound to estrogen receptor alpha	0.134	144	123	6	149	74	216	5.348E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs8-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs8-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-16	0.157	138	111	6	143	79	211	4.594E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujy-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	7ujy-assembly2.cif.gz_D Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	0.138	152	127	2	153	74	221	7.246E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	3uuc-assembly2.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	3uuc-assembly2.cif.gz_C Crystal structure of hERa-LBD (wt) in complex with bisphenol-C	0.104	146	127	7	149	77	222	5.626E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	5e15-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5e15-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol	0.120	179	132	6	184	81	231	6.225E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	5dyb-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5dyb-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-(3,4-dihydronaphthalen-2(1H)-ylidenemethanediyl)diphenol	0.120	184	147	1	184	66	233	4.368E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujy-assembly2.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	7ujy-assembly2.cif.gz_C Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	0.131	150	128	4	151	73	222	5.084E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	5krf-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5krf-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Dynamic WAY derivative, 1a	0.119	184	148	1	184	66	234	3.223E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	5kcc-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5kcc-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Oxabicyclic Heptene Sulfonamide (OBHS-N)	0.137	184	147	1	184	66	236	5.084E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	7qvj-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7qvj-assembly1.cif.gz_A ESTROGEN RECEPTOR ALPHA IN COMPLEX WITH COMPOUND 29	0.122	88	71	87	174	157	238	9.818E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	1gwq-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	1gwq-assembly1.cif.gz_A HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE	0.128	179	141	6	184	80	242	3.223E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	6lz0-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6lz0-assembly1.cif.gz_A Cryo-EM structure of human MCT1 in complex with Basigin-2 in the presence of lactate	0.105	163	144	3	164	189	351	6.548E+00	24
LOKIASV2_3603_ESMFold_hypothetical_protein	3lg7-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	3lg7-assembly1.cif.gz_B Crystal structure of HIV epitope-scaffold 4E10_S0_1EZ3A_002_C	0.101	107	82	56	147	13	119	6.225E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	7u8r-assembly1.cif.gz_o	LOKIASV2_3603_ESMFold_hypothetical_protein	7u8r-assembly1.cif.gz_o Structure of porcine kidney V-ATPase with SidK, Rotary State 3	0.118	143	122	1	139	3	145	5.084E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	5t92-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5t92-assembly1.cif.gz_B ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-{4-[(1R)-2-(4-fluorophenyl)-6-hydroxy-1-methy l-1,2,3,4- tetrahydroisoquinolin-1-yl]phenyl}prop-2-enoic acid	0.132	144	114	1	144	51	182	5.348E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	6cbz-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	6cbz-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Estradiol and GRIP Peptide	0.108	184	147	1	184	57	222	3.752E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	2b23-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	2b23-assembly1.cif.gz_A Human estrogen receptor alpha ligand-binding domain and a glucocorticoid receptor-interacting protein 1 NR box II peptide	0.111	184	148	1	184	62	228	4.368E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	5egv-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5egv-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex the 3,4-diaryl-furan derivative 3-chloranyl-4-[4-(2-chloranyl-4-oxidanyl-phenyl)furan-3-yl]phenol	0.111	184	148	1	184	61	228	5.348E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	3os8-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	3os8-assembly2.cif.gz_D Estrogen Receptor	0.108	153	129	7	159	72	217	3.947E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	6df6-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	6df6-assembly2.cif.gz_D Crystal structure of estrogen receptor alpha in complex with receptor degrader 16ab	0.136	168	144	6	173	64	231	4.152E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	5jmm-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5jmm-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with biochanin A	0.135	184	143	1	184	65	230	5.084E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	6owc-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6owc-assembly1.cif.gz_A Mutant estrogen receptor alpha (ERa) Y537S covalently bound to H3B-6545.	0.138	176	132	7	182	78	231	5.348E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	8du8-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	8du8-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-((1-propylazetidin-3-yl)oxy)phenyl)-3,4-dihydroisoquinolin-2(1H)-yl)(phenyl)methanone	0.150	171	133	4	174	75	232	6.225E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	6zoq-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6zoq-assembly1.cif.gz_A Oestrogen receptor ligand binding domain in complex with compound 16	0.129	167	132	8	174	83	234	3.752E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	7ndo-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7ndo-assembly1.cif.gz_B ER-PRS*(-) (L536S, L372R) in complex with raloxifene	0.142	169	137	5	173	75	235	4.152E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujo-assembly2.cif.gz_D-2	LOKIASV2_3603_ESMFold_hypothetical_protein	7ujo-assembly2.cif.gz_D-2 Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411	0.141	180	138	4	183	78	239	3.752E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	1qkt-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	1qkt-assembly1.cif.gz_A MUTANT ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL	0.142	171	140	4	174	81	244	5.084E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	4ckg-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	4ckg-assembly1.cif.gz_B Helical reconstruction of ACAP1(BAR-PH domain) decorated membrane tubules by cryo-electron microscopy	0.141	163	137	34	196	94	254	4.152E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	4zow-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	4zow-assembly1.cif.gz_A Crystal structure of E. coli multidrug transporter MdfA in complex with chloramphenicol	0.150	151	116	5	141	211	361	9.818E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	8pnl-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	8pnl-assembly1.cif.gz_A Outward-open conformation of a Major Facilitator Superfamily (MFS) transporter MHAS2168, a homologue of Rv1410 from M. tuberculosis, in complex with an alpaca nanobody	0.170	166	133	6	171	12	172	8.873E+00	23
LOKIASV2_3603_ESMFold_hypothetical_protein	7uzg-assembly1.cif.gz_j	LOKIASV2_3603_ESMFold_hypothetical_protein	7uzg-assembly1.cif.gz_j Rat Kidney V-ATPase lacking subunit H, with SidK and NCOA7B, State 1	0.104	139	121	4	139	8	146	9.818E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs8-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs8-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-16	0.142	139	109	6	144	74	201	6.225E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	7rrz-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	7rrz-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	0.135	168	136	6	173	61	218	4.368E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	8dus-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	8dus-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-(2-(ethylamino)ethoxy)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.137	167	129	8	174	70	219	5.626E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	3os9-assembly1.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	3os9-assembly1.cif.gz_C Estrogen Receptor	0.143	177	127	6	182	72	220	5.626E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	5tn9-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5tn9-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	0.137	167	123	7	173	79	222	4.152E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	8dv7-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	8dv7-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(1-propylpyrrolidin-3-yl)ethyl)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.142	171	123	4	174	77	220	5.626E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	8dv5-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	8dv5-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-((1-pentylpyrrolidin-3-yl)methoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.162	145	116	4	148	74	213	6.548E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	5dyd-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5dyd-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3S)-3-(methylsulfanyl)cyclohexylidene]methanediyl}diphenol	0.144	97	65	88	184	148	224	9.333E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	8dui-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	8dui-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-(2-(dimethylamino)ethoxy)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.111	144	126	4	147	70	212	8.435E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujy-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7ujy-assembly1.cif.gz_A Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	0.135	150	126	4	153	76	222	6.888E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	4iv4-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	4iv4-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 5b	0.121	184	146	1	184	62	228	5.348E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	5tlo-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5tlo-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with a Squaric Acid-linked Dimeric Estrogen	0.128	184	144	1	184	63	228	6.888E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	5tlo-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5tlo-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with a Squaric Acid-linked Dimeric Estrogen	0.118	184	146	1	184	65	231	5.084E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties	0.136	142	118	6	147	78	215	8.018E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	7rrz-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7rrz-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	0.132	138	118	6	142	80	217	7.246E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	4iw6-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	4iw6-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 7b	0.126	184	147	1	184	66	234	7.622E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs0-assembly2.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs0-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-18	0.151	141	117	6	144	81	221	8.435E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	4iv2-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	4iv2-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 5a	0.133	184	148	1	184	66	237	4.152E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	5tmv-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5tmv-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS analog, 4-iodophenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	0.144	184	146	1	184	67	238	4.833E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	1gwq-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	1gwq-assembly1.cif.gz_B HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE	0.124	179	142	6	184	79	241	4.594E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	7a0g-assembly1.cif.gz_EEE	LOKIASV2_3603_ESMFold_hypothetical_protein	7a0g-assembly1.cif.gz_EEE Structure of the SmhB pore of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.	0.151	171	143	19	188	140	310	3.752E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	6cjq-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6cjq-assembly1.cif.gz_A Structure of the SthK cyclic nucleotide-gated potassium channel	0.098	148	131	43	190	98	243	8.873E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	4ybq-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	4ybq-assembly1.cif.gz_A Rat GLUT5 with Fv in the outward-open form	0.130	226	158	1	183	6	231	4.152E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	7zh6-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7zh6-assembly1.cif.gz_A Structure of human OCT3 in complex with inhibitor Corticosterone	0.161	162	133	6	167	303	462	6.888E+00	22
LOKIASV2_3603_ESMFold_hypothetical_protein	7udb-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7udb-assembly1.cif.gz_B Cryo-EM structure of a synaptobrevin-Munc18-1-syntaxin-1 complex class 2	0.065	153	118	56	182	23	175	8.873E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujw-assembly2.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7ujw-assembly2.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Possesses Selective Estrogen Receptor Degrader Activities	0.118	144	125	1	144	56	198	7.246E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	8du9-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	8du9-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3,4-dihydroisoquinolin-2(1H)-yl)(phenyl)methanone	0.169	169	126	6	174	69	221	8.018E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	4iui-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	4iui-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY derivative, 4a	0.127	179	127	6	184	74	219	9.818E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	2jfa-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	2jfa-assembly1.cif.gz_B ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH AN AFFINITY-SELECTED COREPRESSOR PEPTIDE	0.137	142	121	6	146	80	221	9.818E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	5kcw-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5kcw-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-trifluoroethyl OBHS-N derivative	0.131	184	136	1	184	67	223	7.246E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	8dv5-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	8dv5-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-((1-pentylpyrrolidin-3-yl)methoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.146	142	120	6	147	73	213	8.435E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	5e0w-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5e0w-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3S)-3-(4-hydroxyphenyl)cyclohexylidene]methanediyl}diphenol	0.123	182	144	1	182	63	227	5.348E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	5duh-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5duh-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-3 analog phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-3-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide	0.131	184	145	1	184	64	231	6.225E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	2qxm-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	2qxm-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Burned Meat Compound PhIP	0.147	182	132	3	184	76	231	7.622E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	6dfn-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6dfn-assembly1.cif.gz_A Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa	0.130	141	121	6	146	80	219	9.818E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	5tll-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5tll-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-2-chloro-4'-hydroxy-4-((hydroxyiminio)methyl)-[1,1'-biphenyl]-3-olate	0.111	184	149	1	184	65	233	7.622E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	1ere-assembly2.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	1ere-assembly2.cif.gz_C HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL	0.121	179	140	6	184	75	234	6.225E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	6vjd-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6vjd-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	0.153	169	136	6	174	74	234	6.888E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs4-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs4-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-8	0.100	173	151	6	174	71	243	6.225E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs4-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs4-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-8	0.136	171	144	6	173	74	244	6.225E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	4lds-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	4lds-assembly1.cif.gz_B The inward-facing structure of the glucose transporter from Staphylococcus epidermidis	0.081	210	168	1	184	1	210	6.888E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	6rw3-assembly2.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	6rw3-assembly2.cif.gz_B The molecular basis for sugar import in malaria parasites.	0.136	233	162	6	193	9	241	5.084E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	8d2w-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	8d2w-assembly1.cif.gz_A Zebrafish MFSD2A isoform B in inward open ligand 2B conformation	0.178	158	113	1	138	229	386	7.246E+00	21
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs3-assembly2.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs3-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-29	0.135	140	112	4	143	68	197	9.333E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	3os9-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	3os9-assembly2.cif.gz_D Estrogen Receptor	0.142	138	107	6	143	70	195	9.333E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	2jf9-assembly1.cif.gz_B-2	LOKIASV2_3603_ESMFold_hypothetical_protein	2jf9-assembly1.cif.gz_B-2 ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST	0.121	152	129	1	148	58	209	9.333E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs0-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs0-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-18	0.157	137	105	6	142	70	195	8.018E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	5e15-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5e15-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol	0.130	177	124	8	184	74	217	7.246E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	6wok-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6wok-assembly1.cif.gz_A Crystal structure of estrogen receptor alpha in complex with receptor degrader 6	0.132	146	121	4	149	71	210	8.873E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	5dks-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5dks-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 2-naphthylamino-substituted, ethyl, triaryl-ethylene derivative 4,4'-{2-[3-(naphthalen-1-ylamino)phenyl]but-1-ene-1,1-diyl}diphenol	0.116	184	143	1	184	64	226	6.888E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	2yat-assembly1.cif.gz_A-2	LOKIASV2_3603_ESMFold_hypothetical_protein	2yat-assembly1.cif.gz_A-2 Crystal structure of estradiol derived metal chelate and estrogen receptor-ligand binding domain complex	0.112	177	132	6	182	75	224	6.888E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	7msa-assembly2.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7msa-assembly2.cif.gz_B GDC-9545 in complex with estrogen receptor alpha	0.142	144	123	6	149	75	218	8.873E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs7-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs7-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	0.100	146	127	6	147	69	214	9.333E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujo-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7ujo-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411	0.143	144	122	4	147	72	214	9.818E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	4tv1-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	4tv1-assembly1.cif.gz_B Crystal structure of hERa-LBD (Y537S) in complex with propylparaben	0.131	184	146	1	184	64	232	9.333E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	5dz0-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5dz0-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(4-methylcyclohexylidene)methanediyl]diphenol	0.131	182	143	1	182	66	230	4.152E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	7kbs-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7kbs-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Raloxifene	0.131	170	136	4	173	77	234	6.548E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties	0.132	171	147	6	175	63	233	8.018E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	1x7r-assembly1.cif.gz_A-2	LOKIASV2_3603_ESMFold_hypothetical_protein	1x7r-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN	0.125	156	128	7	153	72	227	6.888E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	5tly-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5tly-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 3,4-bis(2-fluoro-4-hydroxyphenyl)thiophene 1,1-dioxide	0.115	184	150	1	184	66	235	6.888E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	4mg8-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	4mg8-assembly1.cif.gz_B Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalanol	0.121	184	147	1	184	68	235	6.548E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	2qgt-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	2qgt-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to an Ether Estradiol Compound	0.117	184	150	1	184	66	236	5.348E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	5krc-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5krc-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Zearalenone	0.115	184	150	1	184	66	235	8.435E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	4pps-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	4pps-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with an A-CD ring estrogen derivative	0.112	184	153	1	184	65	237	8.018E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujf-assembly2.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	7ujf-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties	0.157	173	137	3	175	74	236	8.435E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	5tlt-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5tlt-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with octane-1,8-diyl bis(2,3-bis(4-hydroxyphenyl)pentanoate)	0.122	184	151	1	184	66	238	6.225E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	1pq6-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	1pq6-assembly1.cif.gz_B HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX	0.102	163	135	4	166	90	240	8.018E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	1yin-assembly1.cif.gz_A-2	LOKIASV2_3603_ESMFold_hypothetical_protein	1yin-assembly1.cif.gz_A-2 Human estrogen receptor alpha ligand-binding domain in complex with compound 3F	0.130	174	145	9	176	66	239	7.622E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	6sbo-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	6sbo-assembly1.cif.gz_B Estrogen receptor mutant L536S	0.146	145	123	6	150	80	224	8.435E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	2qa6-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	2qa6-assembly1.cif.gz_A Crystal Structure of Estrogen Receptor Alpha mutant 537S Complexed with 4-(6-hydroxy-1H-indazol-3-yl)benzene-1,3-diol	0.137	184	153	1	184	64	241	5.626E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	6zos-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6zos-assembly1.cif.gz_A Oestrogen receptor ligand binding domain in complex with compound 18	0.117	176	153	1	174	68	243	6.225E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs4-assembly2.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs4-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-8	0.132	167	141	7	173	82	244	7.622E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	5u2d-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5u2d-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Oxabicyclic Heptene Sulfonate (OBHS)	0.157	184	147	1	184	66	240	5.084E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	7wn1-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7wn1-assembly1.cif.gz_A Structure of PfNT1(Y190A) in complex with nanobody 48 and inosine	0.113	166	117	4	136	11	176	5.918E+00	20
LOKIASV2_3603_ESMFold_hypothetical_protein	6tz5-assembly1.cif.gz_AA	LOKIASV2_3603_ESMFold_hypothetical_protein	6tz5-assembly1.cif.gz_AA CryoEM reconstruction of membrane-bound ESCRT-III filament composed of CHMP1B+IST1 (left-handed)	0.116	142	118	61	194	4	145	7.622E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs3-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs3-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-29	0.142	170	133	4	173	68	223	6.888E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	1xqc-assembly2.cif.gz_C	LOKIASV2_3603_ESMFold_hypothetical_protein	1xqc-assembly2.cif.gz_C X-ray structure of ERalpha LBD bound to a tetrahydroisoquinoline SERM ligand at 2.05A resolution	0.128	181	136	4	184	67	223	8.018E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	2qxs-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	2qxs-assembly1.cif.gz_B Crystal Structure of Antagonizing Mutant 536S of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Raloxifene	0.148	174	143	1	174	57	225	8.435E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	5u2b-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	5u2b-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol, without a coactivator peptide	0.132	178	131	7	184	72	223	8.873E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	5krk-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5krk-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-((5-bromo-2,3-dihydro-1H-inden-1-ylidene)methylene)diphenol	0.123	184	145	1	184	62	227	7.622E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	6suo-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6suo-assembly1.cif.gz_A ERa_L536S (L536S/C381S/C471S,C530S) in complex with a tricyclic indole (compound 6)	0.136	169	131	6	174	76	228	8.018E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	5dp0-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5dp0-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 4-fluorophenylamino-substituted triaryl-ethylene derivative 4,4'-(2-{3-[(4-fluorophenyl)amino]phenyl}ethene-1,1-diyl)diphenol	0.144	184	141	1	184	63	228	9.333E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	2qa8-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	2qa8-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with Genistein	0.121	184	149	1	184	60	229	5.626E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	4xi3-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	4xi3-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with Bazedoxifene	0.127	158	135	6	163	70	225	9.333E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	5dwi-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5dwi-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 2-Chloro-substituted Diaryl-imine analog 4-[(E)-[(2-chlorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol	0.110	184	149	1	184	64	231	9.818E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	6psj-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6psj-assembly1.cif.gz_A Bazedoxifene in Complex with Y537S Estrogen Receptor Alpha Ligand Binding Domain	0.136	180	138	3	182	67	227	6.548E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	5ehj-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5ehj-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(4aR,8aR)-octahydronaphthalen-2(1H)-ylidenemethanediyl]diphenol	0.110	184	150	1	184	65	233	6.548E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	5drm-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5drm-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 2,5-diarylthiophene-core ligand 4,4'-thiene-2,5-diylbis(3-chlorophenol)	0.141	184	149	1	184	61	234	9.333E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	8dus-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	8dus-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-(2-(ethylamino)ethoxy)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.149	169	133	6	174	78	234	8.435E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	5dzh-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5dzh-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol	0.120	184	146	1	184	66	232	7.246E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	5e19-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5e19-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative methyl {4-[bis(4-hydroxyphenyl)methylidene]cyclohexyl}acetate	0.110	184	152	1	184	66	237	9.818E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	4mg7-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	4mg7-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with ferutinine	0.130	184	149	1	184	66	237	8.018E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	3hlv-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	3hlv-assembly1.cif.gz_A Crystal structure of human Estrogen Receptor Alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide and 16-alpha-hydroxy-estrone ((8S,9R,13S,14R,16R)-3,16-dihydroxy-13-methyl-7,8,9,11,12,14,15, 16-octahydro-6H-cyclopenta[a]phenanthren-17-one	0.130	184	152	1	184	64	239	7.622E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	5kra-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5kra-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE	0.134	184	149	1	184	66	238	7.622E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	4mgb-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	4mgb-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with TCBPA	0.130	179	137	6	184	81	239	5.918E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	5t1z-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5t1z-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Ethoxytriphenylethylene and GRIP Peptide	0.114	182	151	1	182	66	236	8.873E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	3l03-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	3l03-assembly1.cif.gz_B Crystal Structure of human Estrogen Receptor alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II peptide and Estetrol (Estra-1,3,5(10)-triene-3,15 alpha,16alpha,17beta-tetrol)	0.125	183	151	1	183	66	239	8.873E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	4tuz-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	4tuz-assembly1.cif.gz_B Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalenol	0.123	184	154	1	184	66	242	8.018E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	1xp6-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	1xp6-assembly1.cif.gz_A HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 16	0.128	178	146	9	176	66	243	8.435E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	6chw-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	6chw-assembly1.cif.gz_A Estrogen Receptor Alpha Y537S covalently bound to antagonist H3B-5942.	0.139	177	138	6	182	80	240	7.246E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	7rtf-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	7rtf-assembly1.cif.gz_A SthK R120A Closed State	0.115	151	131	41	191	99	247	8.873E+00	19
LOKIASV2_3603_ESMFold_hypothetical_protein	2iok-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	2iok-assembly1.cif.gz_A Human estrogen receptor alpha ligand-binding domain in complex with compound 1D	0.136	148	125	4	149	71	218	9.818E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	5kra-assembly2.cif.gz_E	LOKIASV2_3603_ESMFold_hypothetical_protein	5kra-assembly2.cif.gz_E Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE	0.124	184	145	1	184	61	227	9.333E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	7sfo-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7sfo-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 3-(((2-chloro-5-phenylthieno[2,3-d]pyrimidin-4-yl)amino)methyl)phenol and GRIP Peptide	0.112	183	146	1	183	64	228	9.333E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	5tlg-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5tlg-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-4,4''-dihydroxy-3'-((hydroxyiminio)methyl)-[1,1':2',1''-terphenyl]-4'-olate	0.119	184	147	1	184	61	228	8.873E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	8duh-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	8duh-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-((<i>R</i>)-2-methylpyrrolidin-1-yl)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.121	225	142	1	163	2	226	7.246E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	5dxq-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5dxq-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(1s,5s)-bicyclo[3.3.1]non-9-ylidenemethanediyl]diphenol	0.120	184	144	1	184	67	231	9.333E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	4iv4-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	4iv4-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 5b	0.115	184	146	1	184	66	231	8.018E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	5dug-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5dug-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-2 analog phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-2-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide	0.120	184	147	1	184	66	233	9.818E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	4ivw-assembly3.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	4ivw-assembly3.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 6b	0.121	184	145	1	184	68	233	9.818E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs2-assembly2.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	7rs2-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-23	0.127	177	140	6	182	73	233	8.873E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	6pfm-assembly1.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	6pfm-assembly1.cif.gz_D Crystal structure of GDC-0927 bound to estrogen receptor alpha	0.109	176	140	6	181	76	233	9.818E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	3dt3-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	3dt3-assembly1.cif.gz_A Human Estrogen receptor alpha LBD with GW368	0.157	170	135	6	175	73	233	8.435E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	8ev1-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	8ev1-assembly1.cif.gz_A Dual Modulators	0.117	182	150	1	182	65	235	8.873E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	5tmt-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5tmt-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-((1,3-dihydro-2H-inden-2-ylidene)methylene)diphenol	0.114	184	151	1	184	66	236	8.873E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	4znv-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	4znv-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Methoxy-substituted OBHS derivative	0.121	185	147	1	185	66	233	9.818E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	4dma-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	4dma-assembly1.cif.gz_A Crystal structure of ERa LBD in complex with RU100132	0.131	179	135	6	184	81	236	9.818E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	4ivw-assembly3.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	4ivw-assembly3.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 6b	0.109	184	151	1	184	67	237	8.018E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	7a0g-assembly1.cif.gz_JJJ	LOKIASV2_3603_ESMFold_hypothetical_protein	7a0g-assembly1.cif.gz_JJJ Structure of the SmhB pore of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.	0.151	138	97	4	141	132	246	9.818E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	7oix-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	7oix-assembly1.cif.gz_B Structure of thermostable human MFSD2A in complex with thermostable human Sync2	0.108	226	163	1	184	221	446	9.333E+00	18
LOKIASV2_3603_ESMFold_hypothetical_protein	5kra-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5kra-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE	0.104	220	164	1	184	6	225	7.622E+00	17
LOKIASV2_3603_ESMFold_hypothetical_protein	5kcf-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5kcf-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, 4-methoxybenzyl OBHS-N derivative	0.114	184	142	1	184	66	226	9.818E+00	17
LOKIASV2_3603_ESMFold_hypothetical_protein	5wgq-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5wgq-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Estradiol and SRC2-BCP1	0.115	224	162	1	184	5	228	8.018E+00	17
LOKIASV2_3603_ESMFold_hypothetical_protein	5dkb-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5dkb-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-methylphenylamino-substituted ethyl triaryl-ethylene derivative 4,4'-(2-{3-[(3-methylphenyl)amino]phenyl}but-1-ene-1,1-diyl)diphenol	0.122	184	146	1	184	65	231	8.018E+00	17
LOKIASV2_3603_ESMFold_hypothetical_protein	5dy8-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5dy8-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3S)-3-ethylcyclohexylidene]methanediyl}diphenol	0.145	179	127	6	184	84	233	9.333E+00	17
LOKIASV2_3603_ESMFold_hypothetical_protein	4iu7-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	4iu7-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 2b	0.118	184	147	1	184	67	234	9.818E+00	17
LOKIASV2_3603_ESMFold_hypothetical_protein	4zn9-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	4zn9-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Oxabicyclic Heptene Sulfonate (OBHS)	0.107	224	164	1	185	6	229	6.888E+00	17
LOKIASV2_3603_ESMFold_hypothetical_protein	5tlu-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5tlu-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the PEG-linked Dimeric Estrogen, EE2-(eg)6-EE2-amine	0.121	184	149	1	184	66	236	9.818E+00	17
LOKIASV2_3603_ESMFold_hypothetical_protein	5w9d-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	5w9d-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S Mutant in Complex with Endoxifen	0.152	170	138	6	175	77	240	8.435E+00	17
LOKIASV2_3603_ESMFold_hypothetical_protein	7a0g-assembly1.cif.gz_DDD	LOKIASV2_3603_ESMFold_hypothetical_protein	7a0g-assembly1.cif.gz_DDD Structure of the SmhB pore of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.	0.169	140	111	4	143	133	267	5.626E+00	17
LOKIASV2_3603_ESMFold_hypothetical_protein	5kro-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5kro-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Methyl(phenyl)amino-substituted Estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(methyl(phenyl)amino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol	0.120	183	143	1	183	64	227	9.818E+00	16
LOKIASV2_3603_ESMFold_hypothetical_protein	3l03-assembly1.cif.gz_A	LOKIASV2_3603_ESMFold_hypothetical_protein	3l03-assembly1.cif.gz_A Crystal Structure of human Estrogen Receptor alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II peptide and Estetrol (Estra-1,3,5(10)-triene-3,15 alpha,16alpha,17beta-tetrol)	0.123	224	156	6	184	12	235	8.018E+00	16
LOKIASV2_3603_ESMFold_hypothetical_protein	2qgw-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	2qgw-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with a Chloro-Indazole Compound	0.111	235	163	1	184	6	240	8.435E+00	16
LOKIASV2_3603_ESMFold_hypothetical_protein	6ne5-assembly4.cif.gz_D	LOKIASV2_3603_ESMFold_hypothetical_protein	6ne5-assembly4.cif.gz_D Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors that Demonstrate in vivo Activity in Mouse Xenograft Models of Human Cancer	0.133	140	115	4	137	8	147	9.333E+00	15
LOKIASV2_3603_ESMFold_hypothetical_protein	7uzh-assembly1.cif.gz_b	LOKIASV2_3603_ESMFold_hypothetical_protein	7uzh-assembly1.cif.gz_b Rat Kidney V-ATPase with SidK, State 2	0.155	142	114	3	144	46	181	7.622E+00	15
LOKIASV2_3603_ESMFold_hypothetical_protein	5tm8-assembly1.cif.gz_B	LOKIASV2_3603_ESMFold_hypothetical_protein	5tm8-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, 7-(4-((1R,4S,6R)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)heptanoic acid	0.118	221	161	1	184	7	227	9.333E+00	15
